Qiagen N.V.

NYSE:QGEN Stock Report

Market Cap: US$9.4b

Qiagen Management

Management criteria checks 4/4

Qiagen's CEO is Thierry Bernard, appointed in Oct 2019, has a tenure of 6.08 years. total yearly compensation is $2.34M, comprised of 41.9% salary and 58.1% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth $12.20M. The average tenure of the management team and the board of directors is 7.8 years and 4.8 years respectively.

Key information

Thierry Bernard

Chief executive officer

US$2.3m

Total compensation

CEO salary percentage41.86%
CEO tenure6.1yrs
CEO ownership0.1%
Management average tenure7.8yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

Earnings Beat: Qiagen N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 08
Earnings Beat: Qiagen N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Qiagen's (NYSE:QGEN) Strong Earnings Are Of Good Quality

Sep 02
Qiagen's (NYSE:QGEN) Strong Earnings Are Of Good Quality

Qiagen N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 08
Qiagen N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Qiagen N.V.'s (NYSE:QGEN) Share Price Could Signal Some Risk

Aug 05
Qiagen N.V.'s (NYSE:QGEN) Share Price Could Signal Some Risk

Is Qiagen (NYSE:QGEN) A Risky Investment?

May 10
Is Qiagen (NYSE:QGEN) A Risky Investment?

Analysts Are Updating Their Qiagen N.V. (NYSE:QGEN) Estimates After Its First-Quarter Results

May 10
Analysts Are Updating Their Qiagen N.V. (NYSE:QGEN) Estimates After Its First-Quarter Results

What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You

Apr 20
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You

Qiagen N.V.: Some Clarity Needed Before Buying The Dip

Feb 25

Qiagen N.V.'s (NYSE:QGEN) Share Price Not Quite Adding Up

Jan 10
Qiagen N.V.'s (NYSE:QGEN) Share Price Not Quite Adding Up

Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly

Dec 10
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly
User avatar

Innovative Diagnostics And Tactical Focus Poised To Propel Growth And Margin Enhancement

Expansion in diagnostics with new QIAstat panels and applications, and QuantiFERON's wider adoption following updated guidelines, aim to significantly boost revenue.

CEO Compensation Analysis

How has Thierry Bernard's remuneration changed compared to Qiagen's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

US$405m

Jun 30 2025n/an/a

US$373m

Mar 31 2025n/an/a

US$94m

Dec 31 2024US$2mUS$979k

US$84m

Sep 30 2024n/an/a

US$93m

Jun 30 2024n/an/a

US$73m

Mar 31 2024n/an/a

US$337m

Dec 31 2023US$2mUS$979k

US$341m

Sep 30 2023n/an/a

US$332m

Jun 30 2023n/an/a

US$337m

Mar 31 2023n/an/a

US$353m

Dec 31 2022US$10mUS$950k

US$423m

Sep 30 2022n/an/a

US$488m

Jun 30 2022n/an/a

US$539m

Mar 31 2022n/an/a

US$563m

Dec 31 2021US$2mUS$900k

US$513m

Sep 30 2021n/an/a

US$311m

Jun 30 2021n/an/a

US$480m

Mar 31 2021n/an/a

US$449m

Dec 31 2020US$2mUS$900k

US$359m

Sep 30 2020n/an/a

US$191m

Jun 30 2020n/an/a

US$14m

Mar 31 2020n/an/a

-US$31m

Dec 31 2019US$1mUS$650k

-US$41m

Compensation vs Market: Thierry's total compensation ($USD2.34M) is below average for companies of similar size in the US market ($USD8.50M).

Compensation vs Earnings: Thierry's compensation has been consistent with company performance over the past year.

CEO

Thierry Bernard (61 yo)

6.1yrs
Tenure
US$2,337,567
Compensation

Mr. Thierry Bernard serves as Independent Director of Neogen Corporation since November 01, 2024. He has been Chief Executive Officer of QIAGEN N.V. since March 2020 and also serves as its Member of Manage...

Leadership Team

NamePositionTenureCompensationOwnership
Thierry Bernard
CEO, MD & Member of Management Board6.1yrsUS$2.34m0.13%
$ 12.2m
Roland Sackers
CFO, MD & Member of Management Board21.8yrsUS$1.21m0.18%
$ 17.1m
Antonio Santos
Senior VP & Head of Global Operations3.6yrsno datano data
John Gilardi
VP & Head of Corporate Communications15.1yrsno datano data
Dominic John
Vice President of Marketing & Product Managementno datano datano data
Stephany Foster
Senior VP & Head of Human Resources6.1yrsno datano data
Thomas Schweins
Senior Vice President of Life Science Business Area7.8yrsno datano data
Thomas Theuringer
Senior Director & Head of External Communicationsno datano datano data
Jean-Pascal Viola
Senior VP & Head of Corporate Strategy and Business Development10.5yrsno datano data
Jonathan Sheldon
Senior VP & Head of the QIAGEN Digital Insights Business Area7.8yrsno datano data
Fernando Beils
Senior VP & Head of Global Commercial Operationsno datano datano data
Nitin Sood
Senior VP & Head of Product Portfolio & Innovationno datano datano data
7.8yrs
Average Tenure
53yo
Average Age

Experienced Management: QGEN's management team is seasoned and experienced (7.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephen Rusckowski
Independent Chairman of Supervisory Board2.6yrsUS$82.00k0.000010%
$ 944.6
Metin Colpan
Independent Member of the Supervisory Board & Vice Chair of the Scientific Advisory Board21.8yrsUS$86.50k0.081%
$ 7.7m
Elizabeth Tallett
Independent Member of the Supervisory Board14.4yrsUS$96.25k0.024%
$ 2.3m
Eva Pisa
Independent Member of the Supervisory Board3.4yrsUS$73.75kno data
Toralf Haag
Independent Member of the Supervisory Board4.8yrsUS$82.50k0.0020%
$ 189.9k
Rick Bright
Member of Scientific Advisory Boardno datano datano data
Peter Kaspar
Member of the Scientific Advisory Boardno datano datano data
Ross Levine
Independent Member of the Supervisory Board & Chair of the Scientific Advisory Board9.8yrsUS$68.50k0.0093%
$ 874.7k
Bert van Meurs
Independent Member of the Supervisory Board1.6yrsUS$51.38kno data
Patrice Nordmann
Member of the Scientific Advisory Boardno datano datano data
Neville Sanjana
Member of the Scientific Advisory Boardno datano datano data
Sarah Polonius-Teichmann
Member of the Scientific Advisory Boardno datano datano data
4.8yrs
Average Tenure
64yo
Average Age

Experienced Board: QGEN's board of directors are considered experienced (4.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/09 02:51
End of Day Share Price 2025/11/07 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Qiagen N.V. is covered by 46 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Charles ButlerBarclays
Luke SergottBarclays